Legal Representation
Attorney
Susan D. Rector
USPTO Deadlines
Next Renewal Deadline
1750 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2024-04-23)
Due Date
April 23, 2030
Grace Period Ends
October 23, 2030
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
24 events| Date | Code | Type | Description |
|---|---|---|---|
| Apr 23, 2024 | NRCC | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| Apr 23, 2024 | R.PR | A | REGISTERED-PRINCIPAL REGISTER |
| Feb 6, 2024 | PUBO | A | PUBLISHED FOR OPPOSITION |
| Feb 6, 2024 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Jan 17, 2024 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Jan 2, 2024 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Dec 13, 2023 | XAEC | I | EXAMINER'S AMENDMENT ENTERED |
| Dec 13, 2023 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Dec 13, 2023 | GNEA | O | EXAMINERS AMENDMENT E-MAILED |
| Dec 13, 2023 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN |
| Sep 18, 2023 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Sep 18, 2023 | GNRT | O | NON-FINAL ACTION E-MAILED |
| Sep 18, 2023 | CNRT | R | NON-FINAL ACTION WRITTEN |
| Aug 29, 2023 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Aug 28, 2023 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Aug 28, 2023 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Jul 19, 2023 | XELG | O | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED |
| Jul 19, 2023 | XELR | I | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED |
| Apr 19, 2023 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Apr 19, 2023 | GNRT | F | NON-FINAL ACTION E-MAILED |
| Apr 19, 2023 | CNRT | R | NON-FINAL ACTION WRITTEN |
| Apr 12, 2023 | DOCK | D | ASSIGNED TO EXAMINER |
| Jul 18, 2022 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Jul 1, 2022 | NWAP | I | NEW APPLICATION ENTERED |
Detailed Classifications
Class 045
Tracking and monitoring regulatory requirements in the health, chemical, commercial, clinical, nutritional, medical, veterinary, healthcare, product safety, insurance, consumer packaged goods, pharmaceutical, biopharmaceutical, biotechnology, medical laboratory and clinical laboratory service fields, for regulatory compliance purposes; regulatory compliance consulting in the health, chemical, clinical, commercial, nutritional, medical, veterinary, healthcare, product safety, insurance, consumer packaged goods, pharmaceutical, biopharmaceutical, biotechnology, medical laboratory, clinical laboratory, bioanalytical laboratory, clinical trial, and FDA-regulated product and service fields; providing regulatory information on government health, chemical, clinical, nutritional, medical, veterinary and healthcare products and services, product safety, insurance, pharmaceutical, biopharmaceutical and biotechnology programs; reviewing standards and practices to assure compliance with clinical trial laws and regulations as applied to chemical, commercial, clinical, nutritional, medical, veterinary, pharmaceutical, biopharmaceuticals, biotechnology, and healthcare products and services; regulatory affairs, namely, reviewing standards and practices to assure compliance with clinical trial laws and regulations; assessment of compliance to existing practice guidelines, namely, regulatory compliance consulting in the field of business compliance with country and industry specific regulations; licensing of computer software
First Use Anywhere:
Apr 21, 2022
First Use in Commerce:
Apr 21, 2022
Additional Information
Other
as to "SIKICH"
Classification
International Classes
045
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"INNOVATION LABS"